1.38
0.00%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Sipai Health Technology Co,
Its shares trade on HKEX under the ticker 314.HK. It has been listed since 23 December 2022. In the fiscal year to 31 December 2024, it reported revenue of CN¥4.57bn and a net loss of CN¥323.7m. At that date it held total assets of CN¥2.27bn and shareholders' equity of CN¥1.23bn.
Sipai Health Technology Co., Ltd. operates as a medical technology and health management company. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2022-12-23. The Company’s businesses include Specialty Pharmacy Business, Physician Research Assistance Business and Health Insurance Services Business. Specialty Pharmacy Business includes the operation of offline specialty pharmacies and distribution of pharmaceutical products to pharmaceutical companies and other distributors. Physician Research Assistance Business mainly provides integrated services for pharmaceutical companies to assist them in producing clinical trial data that meets the relevant regulatory standards for the pharmaceutical companies to advance to the next phase of clinical or solicit approval of a treatment by the applicable regulatory body. Health Insurance Services Business provides insurance brokerage services including distribution of various health and life insurance products on behalf of insurance carriers.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Consumer Staples Distribution & Retail
- Listed since
- 23 Dec 2022
- Employees
- 3,174
- Website
- medbankshealthtech.com ↗
Leadership
Pay as last reported
- Mr. Xuguang MaChairman, Chief Executive Officer, Executive Director, since 2015CN¥32.3m
- Mr. Ji LiPresident, Executive Director, since 2015CN¥88.7m
- Mr. Qiang LiChief Operating Officer
- Ms. Na RenGeneral Counsel, Joint Company Secretary
- Mr. Teng ZhouChief Strategy Officer
- Ms. Ching Yi LiJoint Company Secretary
- Mr. Leiwen YaoNon-Executive Director
- Mr. Xin FanNon-Executive Independent Director
- Mr. Haijian HeNon-Executive Independent Director
- Ms. Bei HuangNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Specialty Pharmacy Business operates offline specialty pharmacies and distributes pharmaceuticals to companies and distributors.
- Physician Research Assistance Business provides integrated services for clinical trial data meeting regulatory standards.
- Health Insurance Services Business distributes health and life insurance products on behalf of carriers.
Weaknesses
- Company employs 3,174 full-time employees in Guangzhou, China.
- IPO listed on 23 December 2022 in Guangzhou, China.
- Business operates in Consumer Staples sector with Retail industry in China.
Opportunities
- Specialty Pharmacy Business can expand distribution to more pharmaceutical companies in China.
- Physician Research Assistance Business can grow by assisting more pharmaceutical companies in clinical trials.
- Health Insurance Services Business can increase distribution of health insurance products in China.
Threats
- Regulatory standards for clinical trials may change in China affecting Physician Research Assistance Business.
- Health Insurance Services Business faces competition from other insurance brokers in China.
- Specialty Pharmacy Business faces competition from other pharmacy distributors in China.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.